Paul Lorigan

Manchester Academic Health Science Centre

Also affiliated with University of Manchester, Cancer Research UK Manchester Institute, The Christie Hospital, The Christie NHS Foundation Trust, Manchester University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma”.

Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma

Nature Communications(2020)10.1038/s41467-020-14632-2

N/A

0DataRank · unranked

36 citations

Piyushkumar A. Mundra, Sara Valpione, Pablo García‐Martínez, Matthew Smith, Jonathan Greenall +17 more

Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma

Nature Medicine(2022)10.1038/s41591-022-01695-5

N/A

0DataRank · unranked

438 citations

Andrew Maltez Thomas, Laura A. Bolte, Johannes R. Björk, Laura Kist de Ruijter, Federica Armanini +35 more

Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma

Nature Medicine(2024)10.1038/s41591-024-02803-3

N/A

0DataRank · unranked

131 citations

Laura A. Bolte, Andrew Maltez Thomas, Karla A. Lee, Niccolò Rossi, Thijs T. Wind +35 more

Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial

Cell Reports Medicine(2024)10.1016/j.xcrm.2024.101435

N/A

0DataRank · unranked

20 citations

Richard Marais, Núria Porta, David González de Castro, Lisa Parsons, Christina Messiou +18 more